HAART and risk of tuberculosis in HIV-infected South African children: A multi-site retrospective cohort

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 7, 2009, Pages 862-867

  Martinson, Neil A ^a,b   Moultrie, H ^c   Van Niekerk, R ^a   Barry, G ^a   Coovadia, A ^a   Cotton, M ^d   Violari, A ^a   Gray, G E ^a   Chaisson, R E ^b   McIntyre, J A ^a   Meyers, T ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Cohort; HAART; HIV; Paediatric; Tuberculosis

Indexed keywords

EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD CARE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NEEDLE BIOPSY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX RATIO; SOUTH AFRICA; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK; SOUTH AFRICA; TUBERCULOSIS;

EID: 67651230910     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Resino S, Bellon J M, Resino R, et al. Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children. Clin Infect Dis 2004; 38: 1605-1612. (Pubitemid 38738559)
2. Patel K, Hernan M A, Williams P L, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 2008; 46: 507-515. (Pubitemid 351263487)
3. Sanchez J M, Ramos Amador J T, Fernandez de Miguel S, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003; 22: 863-867. (Pubitemid 37288607)
4. Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, Sherman G. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis 2007; 196 (Suppl 3): S474-S481.
5. Girardi E, Sabin C A, d'Arminio Monforte A, et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 2005; 41: 1772-1782.
6. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064. (Pubitemid 34680968)
7. San-Andres F J, Rubio R, Castilla J, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis 2003; 36: 1177-1185.
8. Marais B J, Obihara C C, Warren R M, Schaaf H S, Gie R P, Donald P R. The burden of childhood tuberculosis: a public health perspective. Int J Tuberc Lung Dis 2005; 9: 1305-1313. (Pubitemid 43265138)
9. Joint United Nations Program on HIV/AIDS. 2006 Report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS, 2006.
10. Connolly C, Shisana O, Colvin M, Stoker D. Epidemiology of HIV in South Africa - results of a national, community-based survey. S Afr Med J 2004; 94: 776-781. (Pubitemid 39264427)
11. Madhi S A, Huebner R E, Doedens L, Aduc T, Wesley D, Cooper P A. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Int J Tuberc Lung Dis 2000; 4: 448-454. (Pubitemid 30256848)
12. Soeters M, de Vries A M, Kimpen J L, Donald P R, Schaaf H S. Clinical features and outcome in children admitted to a TB hospital in the Western Cape - the influence of HIV infection and drug resistance. S Afr Med J 2005; 95: 602-606. (Pubitemid 41167550)
13. Mukadi Y D, Wiktor S Z, Coulibaly I M, et al. Impact of HIV infection on the development, clinical presentation and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 1997; 11: 1151-1158. (Pubitemid 27273613)
14. Palme I B, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 2002; 21: 1053-1061. (Pubitemid 35334515)
15. van Rie A, Beyers N, Gie R P, Kunneke M, Zietsman L, Donald P R. Childhood tuberculosis in an urban population in South Africa: burden and risk factor. Arch Dis Child 1999; 80: 433-437. (Pubitemid 29220178)
16. Department of Health, Republic of South Africa. The South African tuberculosis control programme practical guidelines. Pretoria, South Africa: Department of Health, Republic of South Africa, 2000.
17. Centers for Disease Control and Surveillance. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43: 1-10.
18. Rennert W P, Kilner D, Hale M, Stevens G, Stevens W, Crewe-Brown H. Tuberculosis in children dying with HIV-related lung disease: clinical-pathological correlations. Int J Tuberc Lung Dis 2002; 6: 806-813. (Pubitemid 34988051)
19. Lucas S B, Hounnou A, Koffi K, Beaumel A, Andoh J, De Cock K M. Pathology of paediatric human immunodeficiency virus infections in Cote d'Ivoire. East Afr Med J 1996; 73 (Suppl): S7-S8.
20. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002; 360: 985-990. (Pubitemid 35284110)
21. Walters E, Cotton M F, Rabie H, Schaaf H S, Walters L O, Marais B J. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on antiretroviral therapy. BMC Pediatr 2008; 8: 1. (Pubitemid 351285302)
22. Kouakoussui A, Fassinou P, Anaky M F, et al. Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast. Paediatr Respir Rev 2004; 5: 311-315. (Pubitemid 39462675)
23. World Health Organization. WHO report 2006. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2006.362. Geneva, Switzerland: WHO, 2006.
24. Nesheim S R, Kapogiannis B G, Soe M M, et al. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004. Pediatrics 2007; 120: 100-109.
25. Dankner W M, Lindsey J C, Levin M J. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J 2001; 20: 40-48. (Pubitemid 32066175)
26. Department of Health, Republic of South Africa. Guidelines for the management of HIV infection - 2005. Pretoria, South Africa: Department of Health, Republic of South Africa, 2005.
27. Meintjes G, Lawn S D, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8: 516-523. (Pubitemid 352005824)
28. Mugusi F, Villamor E, Urassa W, Saathoff E, Bosch R J, Fawzi WW. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006; 10: 663-669. (Pubitemid 43845028)
29. Reddi A, Leeper S C, Grobler A C, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr 2007; 7: 13. (Pubitemid 46553973)
30. Newell M L, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364: 1236-1243. (Pubitemid 39311344)
31. Harambat J, Fassinou P, Becquet R, et al. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Cote d'Ivoire: a co-hort study. BMC Public Health 2008; 8: 169.
32. Hussey G D, Reijnhart R M, Sebens A M, Burgess J, Schaaf S, Potgieter S. Survival of children in Cape Town known to be vertically infected with HIV-1. S Afr Med J 1998; 88: 554-558. (Pubitemid 28246358)
33. Schneider H, Kellerman R, Oyedele S. HIV impact surveillance system. Summary report: design and data collection. Johannesburg, South Africa: School of Public Health, University of the Witwatersrand and Gauteng Department of Health, 2005.